ImmuCell Corporation Operating Lease, Payments
ImmuCell Corporation (ICCC) reported Operating Lease, Payments of $689.38 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-30
- ImmuCell Corporation operating lease, payments for the quarter ending 2025-12-31 was $86.00K, a 40.41% decline year-over-year.
- ImmuCell Corporation operating lease, payments for the quarter ending 2025-09-30 was $334.74K, a 131.95% increase year-over-year.
- ImmuCell Corporation operating lease, payments for the quarter ending 2025-06-30 was $124.31K, a 13.86% decline year-over-year.
- ImmuCell Corporation operating lease, payments for the quarter ending 2025-03-31 was $144.31K, a 0.00% change year-over-year.
- ImmuCell Corporation operating lease, payments for fiscal 2025 was $689.38K, a 19.42% increase from fiscal 2024.
- ImmuCell Corporation operating lease, payments for fiscal 2024 was $577.26K, a 132.21% increase from fiscal 2023.
- ImmuCell Corporation operating lease, payments for fiscal 2023 was $248.59K, a 67.63% increase from fiscal 2022.
- ImmuCell Corporation operating lease, payments for fiscal 2022 was $148.30K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $420.75K derived: sum of 2 quarters · filed 2026-03-30 | $545.06K derived: sum of 3 quarters · filed 2026-03-30 | $689.38K 10-K · filed 2026-03-30 |
| 2025-09-30 | $334.74K 10-Q · filed 2025-11-13 | $459.06K derived: sum of 2 quarters · filed 2025-11-13 | $603.37K 10-Q · filed 2025-11-13 | $747.69K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-06-30 | $124.31K 10-Q · filed 2025-08-14 | $268.63K 10-Q · filed 2025-08-14 | $412.94K derived: sum of 3 quarters · filed 2026-03-30 | $557.26K derived: sum of 4 quarters · filed 2026-03-30 |
| 2025-03-31 | $144.31K 10-Q · filed 2025-05-14 | $288.63K derived: sum of 2 quarters · filed 2026-03-30 | $432.94K derived: sum of 3 quarters · filed 2026-03-30 | $577.26K derived: sum of 4 quarters · filed 2026-03-30 |
| 2024-12-31 | $144.31K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $288.63K derived: sum of 2 quarters · filed 2026-03-30 | $432.94K derived: sum of 3 quarters · filed 2026-03-30 | $577.26K 10-K · filed 2026-03-30 |
| 2024-09-30 | $144.31K 10-Q · filed 2025-11-13 | $288.63K derived: sum of 2 quarters · filed 2025-11-13 | $432.94K 10-Q · filed 2025-11-13 | $550.06K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $144.31K 10-Q · filed 2025-08-14 | $288.63K 10-Q · filed 2025-08-14 | $405.75K derived: sum of 3 quarters · filed 2025-08-14 | $475.49K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $144.31K 10-Q · filed 2025-05-14 | $261.43K derived: sum of 2 quarters · filed 2025-05-14 | $331.18K derived: sum of 3 quarters · filed 2025-05-14 | $362.17K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $117.12K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $186.86K derived: sum of 2 quarters · filed 2025-03-28 | $217.85K derived: sum of 3 quarters · filed 2025-03-28 | $248.59K 10-K · filed 2025-03-28 |
| 2023-09-30 | $69.74K 10-Q · filed 2024-11-13 | $100.73K derived: sum of 2 quarters · filed 2024-11-13 | $131.48K 10-Q · filed 2024-11-13 | $189.31K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $30.99K 10-Q · filed 2024-08-13 | $61.73K 10-Q · filed 2024-08-13 | $119.57K derived: sum of 3 quarters · filed 2024-08-13 | $151.04K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $30.74K 10-Q · filed 2024-05-14 | $88.58K derived: sum of 2 quarters · filed 2024-05-14 | $120.05K derived: sum of 3 quarters · filed 2024-05-14 | |
| 2022-12-31 | $57.84K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $89.30K derived: sum of 2 quarters · filed 2024-04-01 | $148.30K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $31.47K 10-Q · filed 2023-11-13 | $90.47K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |